Homburger advised Molecular Partners AG on the offering. Molecular Partners AG, a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin...
You must be a Standard 1 Year member to access this content.
Homburger advised Addex Therapeutics Ltd., Advestra acted for Perceptive Advisors. Addex Therapeutics, a clinical-stage biopharmaceutical company, listed on the SIX Swiss Exchange and on the Nasdaq,...
You must be a Standard 1 Year member to access this content.
Homburger advises Nice & Green SA on the renegotiation of its investment in an equity-linked convertible notes debt instrument issued by Evolva Holding SA. Evolva Holding...
You must be a Standard 1 Year member to access this content.
Homburger advised Addex Therapeutics on the deal. The allosteric modulation company Addex Therapeutics Ltd in Plan-les-Ouates, Geneva (SIX: ADXN) announced that it has completed an equity financing...
You must be a Standard 1 Year member to access this content.
Homburger advised Santhera on the deal. Santhera Pharmaceuticals Holding AG (SIX: SANN) announced a private placement of shares and an amendment of its existing financing with...
You must be a Standard 1 Year member to access this content.
Homburger advised StoneX in this transaction. Lenz & Staehelin advised CDI’s sole shareholder and seller. StoneX Group Inc. (NASDAQ: SNEX), a global financial services company, announced...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised J.P. Morgan on the bridge financing facility of EUR 3.0 billion in connection with the merger of DSM-Firmenich. Homburger AG advised Sentarom...
You must be a Standard 1 Year member to access this content.
Homburger advised Addex in this transaction. Allosteric modulation company Addex Therapeutics Ltd in Plan-les-Ouates, Geneva (SIX: ADXN) announced that it has entered into a definitive agreement...
You must be a Standard 1 Year member to access this content.
Sidley, Homburger and Wolf Theiss advised KKR on the deal. Bär & Karrer acts as legal advisor to Armira and Dr. Urs Spitz in this transaction....
You must be a Standard 1 Year member to access this content.
Homburger advised Santhera in this matter. Santhera Pharmaceuticals annouced a strengthening of its capital structure via placement of private convertible bonds of CHF 15 million and upsizing of...
You must be a Standard 1 Year member to access this content.
Pestalozzi advised H.C. Wainwright on the deal. Homburger advised Santhera. Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular...
You must be a Standard 1 Year member to access this content.
CMS advised Spearhead AG on the deal. Homburger acted as legal counsel to DEKRA SE. In the course of a financing round of Spearhead AG, international...
You must be a Standard 1 Year member to access this content.
